Design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors

Bioorganic & Medicinal Chemistry
2010.0

Abstract

Cell invasion and migration are required for the parent solid tumor cells to metastasize to distant organs. Microtubules form a polarized network, enabling organelle and protein movement throughout the cell. Cytoskeletal elements coordinately regulate cell's motility, adhesion, migration, exocytosis, endocytosis, and division. Thus, microtubule disruption can be a useful target to control cancer cell invasion and metastasis. The phenolic ether methyl eugenol (1), the major component of the essential oil of the leaves of Melaleuca ericifolia Sm. (Myrtaceae), was used as a starting scaffold to design eleven new and three known anti-tubulin agents 2-15 using carbon-carbon coupling reactions. A computer-assisted approach was used to design these new biaryl derivatives using colchicine-binding site of tubulin as the molecular target and colchicine as an active ligand. Several derivatives showed potent inhibitory activity against MDA-MB-231 cell migration at the 1-4microM dose range. The Z isomers, 4 and 15 were more active as invasion inhibitors compared to their structurally related E isomers, 2 and 14. The cytotoxic activities of compounds 2-15 against two breast cancer cell lines MDA-MB-231 and MCF-7 were evaluated. Anti-invasive activity of the semisynthetic derivatives is not due to a direct cytotoxic effect on MDA-MB-231. Analogs 2-15 may promote their anti-invasive activity through the induction of changes in cell morphology. A pharmacophore model was generated involving seven essential features for activity, which was consistent with a previously generated colchicine site inhibitors model.

Knowledge Graph

Similar Paper

Design and pharmacophore modeling of biaryl methyl eugenol analogs as breast cancer invasion inhibitors
Bioorganic & Medicinal Chemistry 2010.0
Design and synthesis of biaryl aryl stilbenes/ethylenes as antimicrotubule agents
European Journal of Medicinal Chemistry 2013.0
Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors
European Journal of Medicinal Chemistry 2021.0
Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors
European Journal of Medicinal Chemistry 2013.0
Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance
European Journal of Medicinal Chemistry 2022.0
Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities
European Journal of Medicinal Chemistry 2018.0
Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors
Bioorganic & Medicinal Chemistry 2013.0
Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors
Bioorganic & Medicinal Chemistry 2017.0
Design, synthesis and biological evaluation of novel chalcone derivatives as antitubulin agents
Bioorganic & Medicinal Chemistry 2012.0
Simple monocyclic pyrimidine analogs as microtubule targeting agents binding to the colchicine site
Bioorganic & Medicinal Chemistry 2023.0